The side-effect ledger: incidence now vs the first two weeks, what reduced each one (and for which biology), what made it worse, and the honest residual — patients where nothing found works yet.

Which side effects, and how do we minimize them?

Synthetic demo data

GI burden ≥ 50 · Companion

first 2 weeks 2% → now 27% (161 patients)

Reduced by

DT-01 100% of 7
HY-01 80% of 5
SC-12 63% of 16
best in Baseline state S14 73%

Made worse by

fat (93%)
simple carbs (70%)
histamine (64%)

Residual · unsolved

2 patients with the pattern and no untried action that improved ≥ 55% of similar cases. This is the number to work on.

Toxicity ≥ 50 · Blood

first 2 weeks 0% → now 15% (89 patients)

Reduced by

GI-04 60% of 5

Made worse by

fat (94%)
simple carbs (68%)
histamine (66%)

Residual · unsolved

0 patients with the pattern and no untried action that improved ≥ 55% of similar cases. This is the number to work on.

Fatigue (energy < 4) · Daily log

first 2 weeks 0% → now 32% (191 patients)

Reduced by

DT-01 100% of 10
HY-01 89% of 9
SC-12 78% of 9
best in Baseline state S14 100%

Made worse by

fat (91%)
simple carbs (73%)
histamine (65%)

Residual · unsolved

8 patients with the pattern and no untried action that improved ≥ 55% of similar cases. This is the number to work on.

Low mood (pessimism > 7) · Daily log

first 2 weeks 4% → now 4% (22 patients)

Reduced by

No action with ≥ 5 instances yet.

Made worse by

poor-sleep weeks
low-HRV stretches
fat (91%)

Residual · unsolved

0 patients with the pattern and no untried action that improved ≥ 55% of similar cases. This is the number to work on.

Poor sleep (quality < 40) · Wearable

first 2 weeks 11% → now 47% (283 patients)

Reduced by

DT-01 100% of 8
HY-01 78% of 9
SC-12 73% of 37
best in Baseline state S14 91%

Made worse by

poor-sleep weeks
low-HRV stretches
fat (69%)

Residual · unsolved

38%

108 patients with the pattern and no untried action that improved ≥ 55% of similar cases. This is the number to work on.